3-Pentadeca-8,11-dienyl-brenzkatechin | 1081768-70-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 3-Pentadeca-8,11-dienyl-brenzkatechin
• 英文别名: Urushiol III；3-[(8E,11E)-pentadeca-8,11-dienyl]benzene-1,2-diol
• CAS: 1081768-70-8
• 化学式: C₂₁H₃₂O₂
• 分子量: 316.484
• InChiKey: RMTXUPIIESNLPW-AOSYACOCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.4
• 重原子数：
  23
• 可旋转键数：
  12
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• COMPOSITION, COMPOSITE PREPARED FROM THE COMPOSITION, ELECTRODE USING THE COMPOSITION OR THE COMPOSITE, COMPOSITE MEMBRANE INCLUDING THE COMPOSITE, AND FUEL CELL INCLUDING THE COMPOSITE MEMBRANE
  申请人：Samsung Electronics Co., Ltd

  公开号：EP2595229B1

  公开（公告）日：2016-02-10
• PATCHES COMPRISING URUSHIOL, TEST PANELS COMPRISING THE SAME, AND METHODS OF USING THE SAME
  申请人：HAPTEN SCIENCES, INC.

  公开号：US20200405886A1

  公开（公告）日：2020-12-31

  Disclosed herein are urushiol-containing epicutaneous patches comprising a support material and a urushiol-containing film on a surface of the support material. A surface of the support material is coated with the urushiol-containing film. Also described herein are test panels comprising urushiol-containing epicutaneous patches of varying urushiol content. The test panels can be employed in methods to assess subject sensitivity to urushiol, to determine a dose-response relationship to varying doses of urushiol, and to assess efficacy of treatments to prevent or inhibit urushiol-induced contact dermatitis in a subject.
• US4002737A
  申请人：——

  公开号：US4002737A

  公开（公告）日：1977-01-11
• US8802315B2
  申请人：——

  公开号：US8802315B2

  公开（公告）日：2014-08-12
• [EN] THERAPEUTIC RELEASE AGENTS<br/>[FR] AGENTS DE LIBÉRATION THÉRAPEUTIQUES
  申请人：ORGANON NV

  公开号：WO2008100977A2

  公开（公告）日：2008-08-21

  [EN] Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. Esters of alkylcarbamic acids are disclosed that are inhibitors of FAAH activity. Compounds disclosed herein inhibit FAAH activity. Described herein are processes for the preparation of esters of alkylcarbamic acid compounds, compositions that include them, and methods of use thereof.
  [FR] L'inhibition pharmacologique de l'activité de l'amide hydrolase d'acides gras (FAAH) entraîne une augmentation des taux d'amides d'acides gras. L'invention concerne des esters d'acides alkylcarbamiques qui constituent des inhibiteurs de l'activité de la FAAH. Les composés décrits inhibent l'activité de la FAAH. L'invention concerne aussi des procédés de préparation d'esters de composés d'acides alkylcarbamiques, des compositions renfermant ceux-ci et des procédés d'utilisation de celles-ci.